Choyke Peter L
Molecular Imaging Program, Building 10, National Cancer Institute, Bethesda, MD 20892, USA.
Sci Transl Med. 2014 Oct 29;6(260):260fs44. doi: 10.1126/scitranslmed.aaa0614.
A phase I study of a tumor-targeted nanoshell in five patients documents an important milestone in the development of nanoparticles for molecular imaging in humans (Phillips et al., this issue).
一项针对五名患者的肿瘤靶向纳米壳的I期研究记录了人类分子成像纳米颗粒开发中的一个重要里程碑(菲利普斯等人,本期)。